What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...

Fintel reports that on November 4, 2025, TD Cowen maintained coverage of Myriad Genetics (NasdaqGS:MYGN) with a Hold ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it ...

In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...

Heart disease in families is a warning, not a destiny. While genes play a role, lifestyle choices hold immense power. Knowing ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.

The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced repeated blows to the head while playing contact sports and there’s now ...

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.05. The announcement from Myriad Genetics is eagerly anticipated, with investors seeking news of surpassing ...

Genetic inheritance may sound straightforward: One gene causes one trait or a specific illness. When doctors use genetics, it's usually to try to identify a disease-causing gene to help guide ...

In announcing that circumcision doubles the rate of autism, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr.

For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a ...

For the first time, scientists have mapped the genetic architecture of the brain’s communication bridge—the corpus callosum—using AI and MRI data from over 50,000 people.